Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic DNA in Normal and Cancerous Prostate Cells

ABSTRACT: To investiagate copy number differences between PrEC and LNCaP cells, each was DNA sequenced. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

ORGANISM(S): Homo sapiens

SUBMITTER: Aaron Statham

PROVIDER: E-GEOD-38674 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Chromatin Looping of Normal and Cancerous Prostate Cells

Project description:Mapping the locations of the DNA binding protein CTCF genome-wide to assess its colocalisation with expression domain boundaries. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38684 | biostudies-arrayexpress

H3K4me3 Marks in Normal and Cancerous Prostate Cells

Project description:H3K4me3 ChIP-seq was done to examine transcription start sites in a genome wide manner, and compare results to CAGE-seq One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38682 | biostudies-arrayexpress

H3K27me3 Marks in Normal and Cancerous Prostate Cells

Project description:The histone modification H3K27me3 is representative of silenced regions of the genome. Changes between the normal and cancer state were investigated. Three PrEC samples, a normal cell line. Four LNCaP sample, a cancer cell line. Technical replicates.

2012-11-30 | E-GEOD-38683 | biostudies-arrayexpress

Mapping of Transcription Start Sites of Normal and Cancerous Prostate Cells

Project description:Capped analysis of gene expression (CAGE) sequencing was done on a normal and a cancer cell line to examine how promoter usage changes between these two states. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38677 | biostudies-arrayexpress

Normal and Cancerous Prostate Cells

Project description:This SuperSeries is composed of the following subset Series: GSE38674: Genomic DNA in Normal and Cancerous Prostate Cells GSE38676: Expression Analysis of Normal and Cancerous Prostate Cells GSE38677: Mapping of Transcription Start Sites of Normal and Cancerous Prostate Cells GSE38682: H3K4me3 Marks in Normal and Cancerous Prostate Cells GSE38683: H3K27me3 Marks in Normal and Cancerous Prostate Cells GSE38684: Chromatin Looping of Normal and Cancerous Prostate Cells Refer to individual Series

2012-10-16 | E-GEOD-38685 | biostudies-arrayexpress

Expression Analysis of Normal and Cancerous Prostate Cells

Project description:Strand-specific RNA sequencing was done on a normal and a cancer cell line to examine how isoforms are used differently between these two states. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38676 | biostudies-arrayexpress

MeDIP-Chip of PrEC, LnCAP, and PC3 cells treated with vehicle control, sulforaphane, or 3,3’-diindolylmethane

Project description:Effects of sulforaphane and 3,3’-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells This study was undertaken to determine the genome-wide effects of sulforaphane (SFN) and 3,3’-diindolylmethane (DIM) on promoter methylation in normal prostate epithelial cells and prostate cancer cells. Nimblegen Human DNA Methylation 3x720K CpG Island Plus RefSeq Promoter Array was used in this study. We hypothesize that both SFN and DIM are effective dietary modulators of DNA methylation due to their inhibitory effects on DNMT expression, and that SFN and DIM can differentially affect the promoter methylation profiles in normal and cancerous prostate epithelial cells. Normal prostate epithelial cells (PrEC), androgen-dependent prostate cancer epithelial cells (LnCAP) and androgen-independent prostate cancer epithelial cells (PC3) were treated with vehicle control, 15uM SFN, or 15uM DIM for 48h in triplicates

2014-01-01 | E-GEOD-47017 | biostudies-arrayexpress

DNA Methylation in IMR90 cells

Project description:DNA methylation was measured by MBD2 enrichment of DNA fragments in IMR90. A statistical model was developed to estimate absolute methylation levels, and compared to whole genome bisulfite sequencing results (Lister, R. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature) Two techincal replicates of MBD2 methylated DNA enrichment in IMR90 cells.

2012-11-30 | E-GEOD-38679 | biostudies-arrayexpress

RNA-Seq anlalysis of prostate cancer cell lines using Next Generation Sequencing

Project description:Beginning with precursor lesions, aberrant DNA methylation marks the entire spectrum of prostate cancer progression. We mapped the global DNA methylation patterns in selected prostate tissues and cell lines using Methylplex-Next Generation Sequencing (M-NGS). Hidden Markov Model based next generation sequence analysis identified ~68,000 methylated regions per sample. While global CpG Island (CGI) methylation was not differential between benign adjacent and cancer samples, overall promoter CGI methylation increased from ~12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues, respectively. We found distinct patterns of promoter methylation around transcription start sites, where methylation occurred not only on the CGIs, but also on flanking regions and CGI sparse promoters. Among the 6,691 methylated promoters in prostate tissues, 2481 differentially methylated regions (DMRs) are cancer specific, including numerous novel DMRs. A novel cancer specific DMR in WFDC2 promoter showed heavy methylation in cancer (17/22 tissues, 6/6 cell lines), but not in the benign tissues (0/10) and normal PrEC cells. Integration of LNCaP DNA methylation and H3K4me3 data suggested an epigenetic mechanism for alternate transcription start site utilization and these modifications segregated into distinct regions when present on the same promoter. Finally, we observed differences in repeat element methylation, particularly LINE-1, between ERG gene fusion positive and negative cancers. This comprehensive methylome map will further our understanding of epigenetic regulation in prostate cancer progression. Next generation Sequencing for Gene expression using the RNA-Seq methodology from LNCaP and PrEC cell lines

2011-05-09 | E-GEOD-29155 | biostudies-arrayexpress

Genomic DNA in Normal and Cancerous Prostate Cells

Project description:To investiagate copy number differences between PrEC and LNCaP cells, each was DNA sequenced.

2012-11-30 | GSE38674 | GEO